Profacgen · Newsroom

MDCK Permeability Assay Now Available at Profacgen
Profacgen, an experienced service provider in molecules discovery and research, recently announced the availability of MDCK permeability assay to simulate the process of drug from the intestinal lumen into the blood.

March 3, 2023

Profacgen Provides a Complete Set of PEGylation Products and Services for Research Use
Profacgen now provides a complete set of PEGylation products and services that can help solubilize biomolecules, reduce immunogenicity of ADCs, or increase circulation stability of drugs.

February 2, 2023

Profacgen Provides a Complete Set of PEGylation Products and Services for Research Use
Profacgen, now provides a complete set of PEGylation products and services that can help solubilize biomolecules, reduce immunogenicity of ADCs, or increase circulation stability of drugs.

January 29, 2023

Profacgen Updated Its In Silico Protein-protein Interactions Prediction Service
Profacgen recently updated its in silico protein-protein interactions prediction service to meet the diversified needs of its customers.

December 14, 2022